SEPSIS DIAGNOSTICS Global Markets by Assay Technology with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024
248 Pages packed with information.
Rapid Results Drive Race for a Sepsis Diagnostic..…
Sepsis is killing over 30 million people a year with no definitive diagnostic in hand. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market. Understand what is driving this huge global diagnostic market and where the opportunity lies.
Our facts and support = Your success.
The report forecasts the market size out to 2024. Growth is coming from the basic factors but technology and education are creating the awareness needed to rapidly expand the diagnostic market. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.
All report data is available in Excel format on request.
Send an email to us at firstname.lastname@example.org and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part. And we will not pester you with phone calls!
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research.
He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research - Burke Institute
Finance for Senior Executives - Harvard Business School